NLE Oncology Nursing — Cancer Pathophysiology, Prevention and DetectionExam Answer Templates
Exam-style answer templates for Cancer Pathophysiology, Prevention and Detection — how to answer NLE Oncology Nursing questions when Professional Regulation Commission (PRC) — Board of Nursing asks about this chapter. Use these as your mental checklist on exam day.
Exam context
The Philippine Nurse Licensure Examination (PNLE) is conducted by Professional Regulation Commission (PRC) — Board of Nursing and is scheduled for Bi-annual. The Oncology Nursing subtest is marked as "Core" in the official pattern, and Cancer Pathophysiology, Prevention and Detection appears in position 1st of 3 in the NLE Oncology Nursing review rotation. Passing mark: 75% weighted average with no sub-test below 60%. Recent NLE 2026 papers have drawn roughly 50 questions from this subject.
Cancer Pathophysiology, Prevention and Detection - Exam Answer Templates
Proper answer writing is one of the most critical — and most overlooked — skills in NLE preparation. Even if you understand the concept, a poorly structured answer can cost you marks that a well-organized response would easily earn. These model templates show you exactly how a perfect answer looks for each mark level: what phrases to use, how much to write, and how to earn every point available. Study each template as a complete unit — question, answer, and scoring rationale — so that when a similar question appears on the board exam, your pen moves with confidence and precision. In Oncology Nursing, clarity and correct use of clinical terminology (e.g., carcinogenesis, TNM staging, metastasis, primary vs. secondary prevention) is what separates passing from failing scores.
Templates
Define carcinogenesis. [1 mark]
Marks
1
Topic
Pathophysiology — Carcinogenesis
Difficulty
easy
Template Id
T1
Examiner Tip
A one-sentence definition that includes the words 'multistep,' 'normal to malignant,' and 'mutation' will always earn this mark. You do not need to list the three stages for a 1-mark item — save that depth for 2- or 3-mark questions.
Model Answer
Carcinogenesis is the multistep process by which normal cells are transformed into malignant (cancer) cells through irreversible genetic mutations caused by carcinogens.
Question Type
very_short_answer
Answer Structure
- One sentence: name the process + describe it as multistep transformation of normal cells into malignant cells through genetic mutation [1 mark]
Scoring Breakdown
Marks
1
Criteria
Correct definition stating that carcinogenesis is the process by which normal cells become malignant through genetic mutation; any equivalent accurate statement earns the mark.
Common Mark Deductions
- Writing 'cancer is caused by carcinogen' without mentioning the transformation of cells or mutation — too vague for a definition mark.
- Confusing carcinogenesis with metastasis.
- Leaving the answer blank because the student tried to memorize a longer definition and panicked.
Key Phrases To Include
- multistep process
- normal cells transformed into malignant cells
- genetic mutations
- carcinogens
What is the difference between a proto-oncogene and a tumor suppressor gene? [1 mark]
Marks
1
Topic
Pathophysiology — Gene Regulation
Difficulty
easy
Template Id
T2
Examiner Tip
Use the analogy of a car: oncogene = accelerator stuck in 'on' position; tumor suppressor = brakes that fail. Examiners recognize this analogy from standard textbooks and reward it.
Model Answer
Proto-oncogenes normally promote healthy cell growth; when mutated into oncogenes, they drive uncontrolled proliferation. Tumor suppressor genes (e.g., p53) normally halt cell division and trigger apoptosis; when inactivated, cell division becomes unregulated.
Question Type
very_short_answer
Answer Structure
- Sentence 1: Define proto-oncogene/oncogene role — accelerator function [½ mark]
- Sentence 2: Define tumor suppressor gene role — brake function [½ mark]
Scoring Breakdown
Marks
1
Criteria
Correctly contrasts the two gene types: proto-oncogene/oncogene = promotes proliferation; tumor suppressor gene = inhibits proliferation/triggers apoptosis. Both parts must be present.
Common Mark Deductions
- Mentioning only one gene type and ignoring the other — the question asks for the difference, so both must appear.
- Saying 'oncogene causes cancer' without explaining the mechanism (mutation of proto-oncogene).
- Omitting p53 or any example, which weakens the answer.
Key Phrases To Include
- proto-oncogene
- oncogene
- uncontrolled proliferation
- tumor suppressor gene
- p53
- apoptosis
- cell division
List the three stages of carcinogenesis and briefly describe each. [3 marks]
Marks
3
Topic
Pathophysiology — Carcinogenesis
Difficulty
medium
Template Id
T3
Examiner Tip
The word 'reversible' in promotion is a classic NLE discriminator. Students who include it demonstrate higher-order understanding and score the full mark. Always write it.
Model Answer
The three stages of carcinogenesis are: 1. Initiation — A carcinogen causes an irreversible mutation in the cell's DNA. The cell is permanently altered but not yet proliferating abnormally. 2. Promotion — Repeated exposure to promoting agents (e.g., tobacco, alcohol, hormones, chronic inflammation) stimulates the mutated cell to proliferate. This stage is reversible, making it the most important window for prevention. 3. Progression — The tumor grows rapidly, develops its own blood supply (angiogenesis), becomes increasingly malignant, invades surrounding tissue, and gains the ability to metastasize to distant organs.
Question Type
short_answer
Answer Structure
- Stage 1 — Initiation: irreversible DNA mutation by carcinogen [1 mark]
- Stage 2 — Promotion: reversible proliferation by promoting agents; prevention window [1 mark]
- Stage 3 — Progression: tumor growth, angiogenesis, invasion, metastasis [1 mark]
Scoring Breakdown
Marks
1
Criteria
Initiation — correctly states it involves irreversible DNA mutation caused by a carcinogen.
Marks
1
Criteria
Promotion — correctly states it involves proliferation of the mutated cell due to promoting agents AND that it is reversible.
Marks
1
Criteria
Progression — correctly states the tumor grows, invades, develops angiogenesis, and can metastasize.
Common Mark Deductions
- Listing all three names but failing to describe each — the question says 'briefly describe each,' so a name alone earns no mark.
- Missing the key word 'reversible' for promotion — this is the distinguishing feature that earns the mark.
- Confusing progression with promotion (e.g., writing that progression is still reversible).
Key Phrases To Include
- initiation
- irreversible mutation
- carcinogen
- promotion
- reversible
- proliferation
- progression
- angiogenesis
- metastasis
- invasion
Enumerate the seven warning signs of cancer using the mnemonic CAUTION. [2 marks]
Marks
2
Topic
Warning Signs of Cancer
Difficulty
easy
Template Id
T4
Examiner Tip
Memorize CAUTION as a complete phrase, not just letters. In the exam, write the letter, a dash, and the full warning sign. This organized format shows mastery and is easy for the examiner to mark.
Model Answer
The seven warning signs of cancer (CAUTION): C — Change in bowel or bladder habits A — A sore that does not heal U — Unusual bleeding or discharge T — Thickening or a lump in the breast or elsewhere I — Indigestion or difficulty swallowing (dysphagia) O — Obvious change in a wart or mole N — Nagging cough or hoarseness
Question Type
short_answer
Answer Structure
- Mnemonic CAUTION written out with each letter correctly expanded — any 4–5 correct = 1 mark; all 7 correct = 2 marks [2 marks total]
Scoring Breakdown
Marks
1
Criteria
Correctly identifies and expands at least 4 of the 7 CAUTION warning signs.
Marks
1
Criteria
Correctly identifies and expands all 7 CAUTION warning signs completely and accurately.
Common Mark Deductions
- Writing the letters C-A-U-T-I-O-N without expanding what each letter stands for.
- Substituting incorrect expansions (e.g., writing 'Cancer' for C instead of 'Change in bowel or bladder habits').
- Missing 3 or more warning signs.
Key Phrases To Include
- CAUTION
- change in bowel or bladder habits
- sore that does not heal
- unusual bleeding or discharge
- thickening or lump
- indigestion or difficulty swallowing
- obvious change in a wart or mole
- nagging cough or hoarseness
Differentiate between benign and malignant tumors. Give at least four characteristics. [2 marks]
Marks
2
Topic
Benign vs. Malignant Tumors
Difficulty
easy
Template Id
T5
Examiner Tip
A table is worth more than a paragraph for comparison questions. Even a simple hand-drawn 3-column table (Characteristic | Benign | Malignant) impresses examiners and keeps you from accidentally writing only one side.
Model Answer
| Characteristic | Benign | Malignant | |---|---|---| | Growth rate | Slow, controlled | Rapid, uncontrolled | | Cell differentiation | Well differentiated; resembles normal tissue | Poorly differentiated or anaplastic | | Capsule/Borders | Encapsulated; well-defined borders | Non-encapsulated; invasive, irregular borders | | Metastasis | Does NOT metastasize | DOES metastasize to distant organs | | Recurrence | Rare after removal | Common after removal | | Effect on host | Usually harmless (unless compressing vital structures) | Often life-threatening |
Question Type
short_answer
Answer Structure
- Table or parallel list format with a heading for each category (Benign vs. Malignant) [organizes answer clearly]
- At least 4 characteristics correctly stated for both benign and malignant — 2 characteristics = 1 mark; 4+ characteristics = 2 marks
Scoring Breakdown
Marks
1
Criteria
Correctly contrasts 2 characteristics between benign and malignant tumors.
Marks
1
Criteria
Correctly contrasts at least 2 additional characteristics — total of 4 or more correctly differentiated.
Common Mark Deductions
- Writing only about benign OR only about malignant — comparison requires BOTH sides for each characteristic.
- Using only 2 characteristics when 4 are asked — reading the question carefully prevents this.
- Stating benign tumors 'are always harmless' — this is incorrect because benign tumors can compress vital structures.
Key Phrases To Include
- well differentiated
- encapsulated
- does not metastasize
- poorly differentiated
- anaplastic
- invasive
- metastasizes
- slow vs. rapid growth
Explain the TNM staging system for cancer. [3 marks]
Marks
3
Topic
Grading and Staging — TNM System
Difficulty
medium
Template Id
T6
Examiner Tip
Write T, N, and M as three clear, separate paragraphs or bullet points. The examiner is marking in real time and appreciates structure. Including 'Tis' for carcinoma in situ and 'M1' for distant metastasis shows command of clinical detail.
Model Answer
The TNM staging system is the international standard for describing the extent of cancer spread in the body. It has three components: T (Tumor) — describes the size and local extent of the primary tumor. T1–T4 indicates increasing size or local invasion. 'Tis' (carcinoma in situ) means the tumor is confined to the layer of origin and has not invaded deeper tissue. N (Nodes) — describes the degree of regional lymph node involvement. N0 means no lymph node spread; N1–N3 indicates increasing nodal involvement. M (Metastasis) — indicates whether distant metastasis is present. M0 means no distant spread; M1 means cancer has spread to distant organs. The T, N, and M values are combined to assign an overall Stage from Stage 0 (carcinoma in situ, most curable) to Stage IV (distant metastasis, most advanced and least curable). A lower stage number generally indicates earlier, more treatable disease.
Question Type
short_answer
Answer Structure
- Opening sentence: name and purpose of TNM system [sets context, not scored separately]
- T component: define with T1–T4 range and Tis [1 mark]
- N component: define with N0 and N1–N3 range [1 mark]
- M component: define with M0 and M1 [1 mark]
Scoring Breakdown
Marks
1
Criteria
T (Tumor) — correctly explains tumor size/extent and mentions T1–T4 or Tis.
Marks
1
Criteria
N (Nodes) — correctly explains lymph node involvement with N0 and N1–N3 or equivalent.
Marks
1
Criteria
M (Metastasis) — correctly explains M0 (absent) vs. M1 (present); bonus if Stage 0–IV overall grouping is mentioned.
Common Mark Deductions
- Writing 'T, N, M' as letters without explaining what each means — the examiner cannot award a mark for unexplained abbreviations.
- Confusing 'staging' with 'grading' in the opening sentence — this signals conceptual confusion.
- Omitting Tis or M1, which are classic NLE discriminators.
Key Phrases To Include
- TNM
- T = Tumor size and extent
- N = regional lymph node involvement
- M = distant metastasis
- Tis = carcinoma in situ
- M0 = no metastasis
- M1 = distant spread
- Stage 0 to Stage IV
Differentiate grading from staging in oncology. [2 marks]
Marks
2
Topic
Grading and Staging
Difficulty
medium
Template Id
T7
Examiner Tip
Memory trick: Grading = G = 'Guts of the cell' (how it looks under microscope). Staging = S = 'Spread' (where it is in the body). Using this distinction in your answer language will prevent the reversal error.
Model Answer
Grading describes the cellular appearance of a tumor — how closely the cancer cells resemble normal cells (degree of differentiation). Grades range from Grade 1 (well differentiated, least aggressive) to Grade 4 (undifferentiated/anaplastic, most aggressive). A higher grade means a more aggressive tumor. Staging describes the anatomical extent of the disease — how far the cancer has spread in the body. The international standard is the TNM system (Tumor, Nodes, Metastasis), producing an overall Stage 0 (carcinoma in situ) through Stage IV (distant metastasis). A higher stage means more widespread disease.
Question Type
short_answer
Answer Structure
- Grading: define as cellular differentiation + Grade 1–4 scale [1 mark]
- Staging: define as extent of spread + TNM or Stage 0–IV reference [1 mark]
Scoring Breakdown
Marks
1
Criteria
Grading — correctly defined as describing cellular differentiation/appearance with Grade 1–4 scale mentioned.
Marks
1
Criteria
Staging — correctly defined as describing extent of spread using TNM system or Stage 0–IV.
Common Mark Deductions
- Reversing the definitions (writing that staging = cellular appearance) — this is the most common error for this topic.
- Not mentioning the Grade 1–4 scale or Stage 0–IV scale — using numbers shows precision.
- Writing only one definition without comparing both.
Key Phrases To Include
- grading
- cellular differentiation
- Grade 1 to Grade 4
- anaplastic
- staging
- extent of spread
- TNM
- Stage 0 to Stage IV
What is the definitive diagnostic test for cancer? Name three tumor markers and the cancer each is used to monitor. [2 marks]
Marks
2
Topic
Diagnosis — Biopsy and Tumor Markers
Difficulty
medium
Template Id
T8
Examiner Tip
The distinction that tumor markers monitor treatment and recurrence rather than make an initial diagnosis is a classic NLE trap. Include this note in your answer to demonstrate clinical precision.
Model Answer
The definitive diagnostic test for cancer is a biopsy — the surgical removal of tissue for histologic (microscopic) examination by a pathologist. Three tumor markers and their associated cancers: 1. PSA (Prostate-Specific Antigen) — used to monitor prostate cancer 2. CA-125 — used to monitor ovarian cancer 3. CEA (Carcinoembryonic Antigen) — used to monitor colorectal cancer Note: Tumor markers are primarily used to monitor treatment response and detect recurrence, NOT as the first-line diagnostic test.
Question Type
short_answer
Answer Structure
- Definitive test = biopsy (must use the word 'biopsy' and briefly describe it) [1 mark]
- Three tumor markers correctly paired with their associated cancer [1 mark — award for at least 2 correct pairs]
Scoring Breakdown
Marks
1
Criteria
Correctly identifies biopsy as the definitive diagnostic test; bonus for noting it involves histologic examination.
Marks
1
Criteria
Names at least 2 tumor markers (PSA, CA-125, CEA, or AFP) correctly matched to their respective cancer type.
Common Mark Deductions
- Writing 'CT scan' or 'PET scan' as the definitive test — imaging supports diagnosis but biopsy confirms it.
- Listing tumor markers without stating what cancer each monitors.
- Stating tumor markers are used for initial diagnosis — they are primarily used to monitor treatment and recurrence.
Key Phrases To Include
- biopsy
- histologic examination
- PSA
- prostate cancer
- CA-125
- ovarian cancer
- CEA
- colorectal cancer
- AFP
- liver/testicular cancer
- monitor treatment response
Enumerate at least four types of carcinogens with one example each. [2 marks]
Marks
2
Topic
Pathophysiology — Carcinogens
Difficulty
medium
Template Id
T9
Examiner Tip
Philippine-context examples strengthen your answer. Mentioning aflatoxin (from improperly stored rice or corn) is culturally relevant and shows applied knowledge. HPV causing cervical cancer is also high-yield given DOH's national HPV vaccination program.
Model Answer
Carcinogens are agents that cause cancer by inducing irreversible genetic mutations. Four types with examples: 1. Chemical carcinogens — tobacco smoke, benzene, asbestos, aflatoxin (from mold in grains) 2. Physical carcinogens — ultraviolet (UV) radiation (from sun exposure), ionizing radiation (from X-rays or nuclear material) 3. Biological/Infectious agents — Human Papillomavirus (HPV) causes cervical cancer; Hepatitis B and C viruses cause liver cancer; Helicobacter pylori causes gastric cancer 4. Hormonal carcinogens — prolonged estrogen exposure linked to breast and endometrial cancer
Question Type
short_answer
Answer Structure
- Opening definition of carcinogen (optional, adds clarity)
- Type 1 with correct example [½ mark]
- Type 2 with correct example [½ mark]
- Type 3 with correct example [½ mark]
- Type 4 with correct example [½ mark — total 2 marks for 4 types with examples]
Scoring Breakdown
Marks
1
Criteria
Names and gives an example for at least 2 types of carcinogens correctly.
Marks
1
Criteria
Names and gives an example for at least 2 additional types — total of 4 correct type-example pairs.
Common Mark Deductions
- Listing only examples (e.g., 'tobacco, asbestos, HPV') without categorizing them into type — the question asks for types with examples.
- Naming a carcinogen category twice (e.g., listing both asbestos and benzene as two separate types when both are chemical carcinogens).
- Confusing H. pylori (a bacterium) as a virus — specificity matters.
Key Phrases To Include
- chemical carcinogens
- tobacco
- physical carcinogens
- UV radiation
- ionizing radiation
- biological/infectious agents
- HPV
- Hepatitis B
- Helicobacter pylori
- hormonal factors
- estrogen
Explain the process of metastasis and name the four most common sites to which cancer spreads. [3 marks]
Marks
3
Topic
Pathophysiology — Invasion and Metastasis
Difficulty
medium
Template Id
T10
Examiner Tip
The statement that 'a metastasis keeps the cell type of its origin' is a classic discriminator item in NLE. Include it even if not explicitly asked — it demonstrates depth of understanding and earns bonus recognition.
Model Answer
Metastasis is the spread of cancer cells from the primary tumor site to distant organs or tissues, forming secondary tumors. It is the defining feature that distinguishes malignant from benign tumors. Metastasis occurs through four routes: 1. Direct extension — cancer cells invade and grow into adjacent tissues. 2. Lymphatic spread — cancer cells enter lymph vessels and travel to regional lymph nodes; this is the most common route for carcinomas. 3. Hematogenous (bloodstream) spread — cancer cells enter blood vessels and are carried to distant organs. 4. Transcoelomic (seeding) spread — cancer cells shed into body cavities (e.g., peritoneal, pleural) and implant on organ surfaces. The four most common sites of metastasis are: 1. Lungs 2. Liver 3. Bone 4. Brain Important note: A metastatic tumor retains the cell type of the primary tumor. For example, breast cancer that spreads to the bone is still breast cancer, not bone cancer.
Question Type
short_answer
Answer Structure
- Definition of metastasis [½ mark — earns mark when combined with routes]
- At least two routes of spread correctly described [1 mark]
- Four common sites of metastasis: lungs, liver, bone, brain [1 mark]
- Note that metastatic tumor retains cell type of origin [½ mark — bonus/discriminator]
Scoring Breakdown
Marks
1
Criteria
Definition of metastasis plus at least one route of spread correctly described.
Marks
1
Criteria
At least two additional routes of spread correctly named (lymphatic, hematogenous, direct extension, seeding).
Marks
1
Criteria
Names all four common metastatic sites: lungs, liver, bone, and brain.
Common Mark Deductions
- Naming only one route of spread — the question expects the student to know multiple mechanisms.
- Not naming all four metastatic sites — writing only 'lungs and liver' loses ½ mark.
- Stating a metastatic tumor takes on the character of the new site (e.g., 'bone cancer' when breast spreads to bone) — this is clinically wrong.
Key Phrases To Include
- metastasis
- spread from primary tumor
- lymphatic system — most common route for carcinomas
- hematogenous
- direct extension
- transcoelomic/seeding
- lungs, liver, bone, brain
- retains cell type of origin
Distinguish between primary and secondary prevention of cancer, and give two nursing interventions for each. [5 marks]
Marks
5
Topic
Prevention and Early Detection
Difficulty
hard
Template Id
T11
Examiner Tip
For 5-mark long answers, use headings (I. PRIMARY PREVENTION / II. SECONDARY PREVENTION). Examiners follow a marking key that often assigns 1 mark per major point, and clear headings ensure your points are easy to identify. Referencing RA 9173 and the DOH demonstrates Philippine nursing professional context — this is uniquely rewarded in NLE-style exams.
Model Answer
Cancer prevention is classified into two levels based on the stage at which the nurse intervenes. I. PRIMARY PREVENTION Definition: Primary prevention aims to prevent cancer from developing by reducing or eliminating exposure to risk factors (carcinogens) before the disease begins. It targets the initiation and promotion stages of carcinogenesis. Key strategies: - Avoidance of tobacco (smoking cessation counseling) — tobacco is the single most important modifiable risk factor, linked to lung, oral, esophageal, and bladder cancers. - Vaccination: HPV vaccine (prevents cervical and other HPV-related cancers) and Hepatitis B vaccine (prevents liver cancer). In the Philippines, the DOH provides free HPV vaccination for Grade 4 girls as part of its national immunization program. - Healthy lifestyle promotion: balanced diet rich in fiber, fruits, and vegetables; limited alcohol; maintenance of healthy weight; regular physical activity. - Sun protection: sunscreen use, protective clothing, and avoiding prolonged UV exposure to prevent skin cancer. - Occupational safety: limiting exposure to asbestos, benzene, and ionizing radiation. Two nursing interventions for primary prevention: 1. Conduct community health education sessions on smoking cessation, healthy diet, and HPV/Hepatitis B vaccination, emphasizing the link between modifiable behaviors and cancer risk. 2. Administer or facilitate administration of the HPV vaccine and Hepatitis B vaccine to eligible clients, following the Philippine DOH immunization schedule, and document vaccination status accurately. II. SECONDARY PREVENTION Definition: Secondary prevention involves early detection of cancer or precancerous conditions before symptoms appear, so that treatment can begin when the disease is most curable. It targets the progression stage. Key screening strategies: - Breast: Monthly breast self-examination (BSE), clinical breast examination, and mammography. - Cervical: Pap smear (Papanicolaou smear) to detect precancerous cervical changes; HPV co-testing. - Colorectal: Fecal occult blood test (FOBT) and colonoscopy. - Prostate: PSA testing and digital rectal examination. - Testicular: Monthly testicular self-examination in young men. - Skin: Self-inspection using the ABCDE rule (Asymmetry, Border irregularity, Color variation, Diameter >6 mm, Evolving). Two nursing interventions for secondary prevention: 1. Teach and demonstrate breast self-examination (BSE) and testicular self-examination techniques to clients of appropriate age, explaining the correct monthly timing and what findings to report (e.g., a lump, discharge, or any CAUTION warning sign). 2. Refer female clients for regular Pap smear screening and mammography, explaining the purpose, procedure, and schedule; advocate for access to DOH-provided free cervical cancer screening available at rural health units (RHUs) and health centers. Nursing note: Cultural barriers common in Filipino clients — including fatalism ('bahala na'), privacy concerns, and fear of diagnosis — must be acknowledged and addressed through therapeutic communication and family involvement to promote adherence to screening programs. Under RA 9173 (Philippine Nursing Act of 2002), nurses are mandated to provide health education and community health services, which encompasses both levels of cancer prevention.
Question Type
long_answer
Answer Structure
- Part I — Primary Prevention: clear definition distinguishing it from secondary prevention [1 mark]
- Key strategies for primary prevention listed with at least 3 examples [1 mark]
- Two specific, actionable nursing interventions for primary prevention [1 mark]
- Part II — Secondary Prevention: clear definition with examples of screening tests by body system [1 mark]
- Two specific, actionable nursing interventions for secondary prevention; Philippine context (DOH, RHU, RA 9173) mentioned [1 mark]
Scoring Breakdown
Marks
1
Criteria
Correct definition of primary prevention — preventing cancer from developing by reducing carcinogen exposure.
Marks
1
Criteria
Lists at least 3 key primary prevention strategies accurately (tobacco avoidance, HPV/Hep B vaccine, healthy diet, sun protection, occupational safety).
Marks
1
Criteria
States two specific and actionable nursing interventions for primary prevention.
Marks
1
Criteria
Correct definition of secondary prevention — early detection through screening before symptoms appear.
Marks
1
Criteria
States two specific and actionable nursing interventions for secondary prevention; mention of Philippine healthcare context (DOH, RHU, RA 9173, or national program) earns this mark.
Common Mark Deductions
- Failing to define either primary or secondary prevention — just listing interventions without context loses 2 marks.
- Giving interventions that are the same for both levels — each section must have distinct, level-appropriate interventions.
- Not mentioning any Philippine context in a 5-mark answer — the examiner expects local clinical relevance.
- Listing general nursing actions (e.g., 'provide emotional support') that are not specific to cancer prevention.
- Writing in paragraph form without clear Part I / Part II structure — makes the answer hard to score and risks missing elements.
Key Phrases To Include
- primary prevention
- reduce or eliminate carcinogen exposure
- HPV vaccine
- Hepatitis B vaccine
- smoking cessation
- secondary prevention
- early detection
- Pap smear
- mammography
- breast self-examination
- ABCDE rule
- fecal occult blood test
- DOH
- RA 9173
- RHU
- CAUTION warning signs
A 45-year-old Filipina presents at the rural health unit (RHU) with a 3-week history of a painless lump in the right breast and bloodstained nipple discharge. She has not had a Pap smear in 5 years. Using the nursing process, identify the priority nursing diagnosis, one subjective and one objective cue, and two priority nursing interventions. [5 marks]
Marks
5
Topic
Nursing Management — Prevention and Early Detection
Difficulty
hard
Template Id
T12
Examiner Tip
Case-study items reward the student who follows the nursing process sequence visibly: Assessment → Diagnosis → Intervention → Evaluation. Label each section. For oncology case studies, always link your interventions to the level of prevention (primary or secondary) — this demonstrates clinical reasoning beyond memorization.
Model Answer
ASSESSMENT — CUES: Subjective cue: 'Mayroon akong bukol sa kanang suso at may dugo na lumalabas sa utong ko.' (Patient reports a painless lump in the right breast and bloodstained nipple discharge for 3 weeks.) Objective cue: Palpable, painless mass in the right breast on clinical examination; presence of bloodstained nipple discharge noted; no Pap smear done in the last 5 years. PRIORITY NURSING DIAGNOSIS (NANDA): Anxiety related to perceived threat of cancer diagnosis and diagnostic workup as evidenced by patient's report of fear and concern over her breast lump and discharge (fear/anxiety is prioritized using Maslow's hierarchy — Love and Belonging and Safety needs are threatened; physiologic safety is also at risk). Alternative physiologic priority: Deficient Knowledge regarding breast cancer warning signs, screening, and the need for prompt diagnostic evaluation, as evidenced by delayed help-seeking (3-week history) and lapsed cervical cancer screening. PRIORITY NURSING INTERVENTIONS: 1. Facilitate immediate referral for diagnostic workup: Explain to the patient the importance of prompt evaluation. Coordinate referral to a physician for clinical breast examination, breast ultrasound or mammography, and biopsy if indicated. Reinforce that a definitive cancer diagnosis requires biopsy — histologic examination is the gold standard. This addresses the patient's physiologic safety need (Maslow's Level 2). 2. Provide targeted health education and emotional support: Explain the CAUTION warning signs and why this patient's symptoms (lump + unusual discharge) require immediate evaluation. Perform or teach correct technique for monthly breast self-examination (BSE). Address any cultural barriers (e.g., fatalism, reluctance to seek care, family decision-making) using therapeutic communication. Refer the patient for overdue Pap smear screening (available at RHU at no cost under DOH programs), consistent with secondary prevention. Document all teaching per RA 9173 standards for nursing documentation. EVALUATION CRITERIA: Patient verbalizes understanding of warning signs and agrees to follow through with referral and diagnostic workup. Patient demonstrates correct BSE technique. Referral for Pap smear is completed.
Question Type
case_study
Answer Structure
- One subjective cue correctly identified from the scenario [½ mark]
- One objective cue correctly identified from the scenario [½ mark]
- Priority nursing diagnosis stated in correct NANDA format (Problem + Etiology + Signs/Symptoms) [1 mark]
- First nursing intervention: referral for diagnostic workup including mention of biopsy as definitive test [1 mark]
- Second nursing intervention: health education including BSE, CAUTION, Pap smear referral, and/or cultural considerations [1 mark]
- Philippine healthcare context (RHU, DOH, RA 9173, or free screening) mentioned [1 mark]
Scoring Breakdown
Marks
1
Criteria
One subjective cue (½) and one objective cue (½) correctly identified from the clinical scenario.
Marks
1
Criteria
Priority nursing diagnosis correctly stated in NANDA PES format (Problem + Etiology + Signs/Symptoms); Anxiety or Deficient Knowledge is appropriate; the diagnosis must match the cues.
Marks
1
Criteria
First nursing intervention: referral for diagnostic workup; mention of biopsy as the definitive test earns full mark.
Marks
1
Criteria
Second nursing intervention: health education on BSE, CAUTION signs, or Pap smear referral, with therapeutic communication noted.
Marks
1
Criteria
Philippine healthcare context integrated appropriately: RHU, DOH free screening, or RA 9173 professional accountability referenced.
Common Mark Deductions
- Stating the nursing diagnosis without the NANDA PES format (Problem + Etiology + Evidence) — partial credit at best.
- Listing only assessment data without proceeding to diagnosis and interventions — the question specifically asks for both.
- Providing generic interventions ('monitor vital signs,' 'provide comfort') that are not specific to the oncology/screening context.
- Failing to mention biopsy as the definitive test when the question scenario involves a suspected cancer — this is a major knowledge gap.
- Not referencing any Philippine healthcare delivery element in a case set in an RHU.
Key Phrases To Include
- NANDA nursing diagnosis
- Anxiety related to
- Deficient Knowledge
- subjective cue
- objective cue
- biopsy — definitive diagnostic test
- referral for diagnostic workup
- breast self-examination (BSE)
- CAUTION warning signs
- Pap smear
- RHU
- DOH
- RA 9173
- secondary prevention
- cultural barriers
- Maslow's hierarchy
Name the leading cancers in the Philippines and state the Philippine law that governs the national cancer control program. [2 marks]
Marks
2
Topic
Cancer Epidemiology in the Philippines
Difficulty
easy
Template Id
T13
Examiner Tip
Memorize 'RA 11215 = NICCA = 2019' as a fixed triple. In the Philippine nursing board exam, legislation questions reward exact recall of the law number and its common name. Do not confuse this with RA 9173 (Nursing Act of 2002).
Model Answer
The leading cancers in the Philippines (in order of frequency/mortality) are: 1. Breast cancer — the most common cancer among Filipino women and overall 2. Lung cancer — strongly linked to high smoking rates; leading cause of cancer death in men 3. Colorectal cancer 4. Liver cancer — associated with Hepatitis B virus infection, which is endemic in the Philippines 5. Cervical cancer — associated with Human Papillomavirus (HPV) 6. Prostate cancer The governing Philippine law for the national cancer control program is: Republic Act No. 11215, also known as the National Integrated Cancer Control Act (NICCA), signed into law in 2019. It established a comprehensive national cancer control program covering prevention, early detection, treatment, survivorship, and financial protection for cancer patients, and created the Cancer Assistance Fund.
Question Type
short_answer
Answer Structure
- At least 4 leading cancers in the Philippines correctly listed [1 mark]
- RA 11215 / NICCA named with year and brief description of its purpose [1 mark]
Scoring Breakdown
Marks
1
Criteria
Names at least 4 of the 6 leading cancers in the Philippines correctly (breast, lung, colorectal, liver, cervical, prostate).
Marks
1
Criteria
Correctly identifies RA 11215 / NICCA and states its purpose as the national cancer control law.
Common Mark Deductions
- Listing fewer than 4 cancers — the question implies a comprehensive list.
- Citing RA 9173 (Philippine Nursing Act) as the cancer law — RA 9173 governs nursing practice, not cancer control.
- Omitting the year (2019) or the full name of the law — NLE items often test the exact law name and number.
Key Phrases To Include
- breast cancer — most common among Filipino women
- lung cancer
- colorectal cancer
- liver cancer
- cervical cancer
- prostate cancer
- Republic Act 11215
- National Integrated Cancer Control Act (NICCA)
- 2019
- Cancer Assistance Fund
- DOH
What is the ABCDE rule used in early detection of skin cancer? [1 mark]
Marks
1
Topic
Secondary Prevention — Skin Cancer Screening
Difficulty
easy
Template Id
T14
Examiner Tip
The E in ABCDE (Evolving) is the newest and most clinically significant addition — examiners frequently test whether students know all five. A changing mole is the most important warning sign of melanoma.
Model Answer
The ABCDE rule is a self-inspection guide for detecting potentially malignant skin lesions (moles): A — Asymmetry (one half does not match the other) B — Border irregularity (edges are ragged, notched, or blurred) C — Color variation (uneven color; multiple shades of tan, brown, or black) D — Diameter greater than 6 mm (about the size of a pencil eraser) E — Evolving (any change in size, shape, color, or new symptoms such as bleeding)
Question Type
very_short_answer
Answer Structure
- ABCDE expanded correctly with all 5 components described [1 mark — award if at least 4 of 5 are correct]
Scoring Breakdown
Marks
1
Criteria
Correctly expands at least 4 of the 5 ABCDE components with their meaning (Asymmetry, Border, Color, Diameter >6mm, Evolving).
Common Mark Deductions
- Writing only the letters (A, B, C, D, E) without expanding what each stands for.
- Stating 'D = Depth' instead of 'D = Diameter >6 mm' — this is a common error.
- Missing the 'E = Evolving' component, which is the most recently added and clinically important criterion.
Key Phrases To Include
- Asymmetry
- Border irregularity
- Color variation
- Diameter greater than 6 mm
- Evolving
- mole
- skin cancer
Explain how apoptosis failure contributes to cancer development. [1 mark]
Marks
1
Topic
Pathophysiology — Normal Cell Regulation
Difficulty
medium
Template Id
T15
Examiner Tip
Even in a 1-mark question, write a mini-chain of reasoning: apoptosis fails → abnormal cells survive → they proliferate → cancer grows. This chain demonstrates pathophysiologic understanding rather than rote recall.
Model Answer
Apoptosis is programmed cell death — the normal mechanism by which old, damaged, or abnormal cells are eliminated. In cancer, mutations (particularly in tumor suppressor genes such as p53) disable the apoptosis pathway, so abnormal cells that should die instead survive and continue to proliferate, accumulating genetic mutations and contributing to tumor growth.
Question Type
very_short_answer
Answer Structure
- Define apoptosis as programmed cell death [sets context]
- Explain that cancer cells escape apoptosis due to gene mutation (p53), allowing abnormal cells to survive and proliferate [1 mark]
Scoring Breakdown
Marks
1
Criteria
Correctly explains that cancer cells evade programmed cell death (apoptosis) due to mutation in tumor suppressor genes, allowing abnormal cells to accumulate and proliferate instead of dying.
Common Mark Deductions
- Defining apoptosis correctly but not connecting its failure to cancer development — the answer must link the two.
- Omitting any mention of the genetic mechanism (p53 or tumor suppressor genes) — vague answers score partial credit at best.
Key Phrases To Include
- apoptosis
- programmed cell death
- tumor suppressor gene
- p53
- abnormal cells survive
- proliferate
- mutation
Mark Wise Strategy
Dos
- Write one complete, accurate sentence.
- Use the exact clinical term — e.g., 'Biopsy is the definitive diagnostic test,' not just 'biopsy.'
- For mnemonics (CAUTION, ABCDE), list all components with their expansions.
- Define the term first, then add one supporting detail if needed.
- Move on after writing 1–2 sentences — do not over-explain.
Donts
- Do not write a paragraph — time is wasted and it does not earn extra marks.
- Do not use vague language like 'something related to cancer cells.'
- Do not leave it blank — partial credit for a close answer is possible.
- Do not confuse related terms (e.g., grading vs. staging, biopsy vs. imaging).
Marks
1
Strategy
For 1-mark questions, write one precise, direct sentence that contains the key term or concept. Do not elaborate excessively — every second matters. Use the exact clinical vocabulary (e.g., 'apoptosis,' 'biopsy,' 'metastasis') rather than lay language. If it is an enumeration, give the complete name, not just an abbreviation.
Expected Length
1–2 sentences or a short enumeration
Time Allocation
1–2 minutes
Dos
- Use a table format for comparison questions — it is faster and clearer.
- Write two clearly distinct points, each earning one mark.
- Include at least one specific example or clinical detail per point.
- Label your points (1. and 2.) so the examiner can identify each separately.
- For CAUTION or tumor marker questions, write all required items — do not assume partial lists earn full marks.
Donts
- Do not write one long sentence that blurs two different points — separate them clearly.
- Do not focus entirely on one half of a comparison and ignore the other.
- Do not omit examples when the question asks for 'examples' — this costs marks directly.
- Do not confuse PSA (prostate) with CA-125 (ovarian) or CEA (colorectal) — accuracy in tumor marker matching is essential.
Marks
2
Strategy
For 2-mark questions, think in halves: each mark is one complete point. For comparison questions (benign vs. malignant, grading vs. staging), a 2-column or 3-column table is the most efficient format. For enumeration, list at least 4 items with brief explanations. Always check that both sides of a comparison are addressed.
Expected Length
3–5 sentences or a small table
Time Allocation
3–4 minutes
Dos
- Plan your 3 points mentally before writing (30 seconds of planning prevents missing a mark).
- Use numbered labels — '1. Initiation: …, 2. Promotion: …, 3. Progression: …'
- For each point, include the key distinguishing word (e.g., 'reversible' for promotion, 'Tis' for T staging).
- After writing all 3 points, quickly review that all 3 are present and distinctly explained.
- Write complete explanations — a list of 3 single words earns 0 marks.
Donts
- Do not write a continuous paragraph with all 3 points embedded — it is hard to identify and may be under-credited.
- Do not repeat the same information using different words to fill space.
- Do not omit the clinical/mechanistic explanation — e.g., for metastasis, writing only 'cancer spreads' without naming the routes earns partial credit.
- Do not spend more than 7 minutes on a 3-mark question — it is not a 5-mark item.
Marks
3
Strategy
For 3-mark questions, plan your answer before writing: identify 3 distinct points you need to cover. Use numbered or bulleted format. Each bullet must be substantive — a label alone does not earn a mark; a label with an accurate explanation does. For process questions (carcinogenesis stages, TNM components), write each stage/component as a separate labeled entry with its key distinguishing feature.
Expected Length
One short paragraph per point, or 3 labeled bullet points
Time Allocation
5–7 minutes
Dos
- Use bold headings or Roman numerals (I, II) to organize major sections.
- State definitions at the start of each major section.
- Include at least 2 specific, actionable nursing interventions rather than general statements.
- Reference Philippine legislation or healthcare delivery (RA 9173, RA 11215, DOH, RHU, PhilHealth) — this is expected in NLE-level extended answers.
- Allocate roughly 2–3 minutes for planning before writing — a well-planned 5-mark answer scores higher than a disorganized but longer one.
- End with an evaluation or patient outcome statement — this completes the nursing process and signals competency.
Donts
- Do not write a single unbroken block of text — this makes the examiner's job harder and risks your marks being undercounted.
- Do not pad the answer with irrelevant information — quantity without quality does not earn marks.
- Do not use generic nursing interventions ('assess,' 'monitor,' 'provide support') without specificity — 'teach BSE technique demonstrating correct monthly timing' is specific; 'provide education' is not.
- Do not exceed 15 minutes — time management in the NLE is critical; an over-long 5-mark answer steals time from other questions.
- Do not forget the patient's perspective — especially for case studies, address communication, cultural factors, and emotional support.
Marks
5
Strategy
For 5-mark questions, use a structured essay format with clear headings. Treat each major component as worth approximately 1 mark and plan accordingly. Include a brief introduction (1–2 sentences), the main body (3–4 subpoints, each clearly labeled), and a brief conclusion or evaluation note. For clinical/nursing process questions, follow the ADPIE format explicitly. Always include Philippine nursing context (RA 9173, RA 11215, DOH, RHU) in at least one part of the answer.
Expected Length
3–4 short paragraphs, organized under clear subheadings
Time Allocation
10–15 minutes
General Answer Writing Tips
- Always define your key term first — for any concept question (e.g., 'What is carcinogenesis?'), open with a one-sentence definition before explaining or elaborating. Examiners award the first mark for the definition.
- Use the mnemonic CAUTION exactly as spelled — writing the full mnemonic and listing all seven warning signs in order shows structured recall and earns full marks for warning sign questions.
- Distinguish grading from staging using parallel structure: 'Grading describes how abnormal the cells look (Grade 1–4); staging describes how far the cancer has spread (Stage 0–IV, TNM system).' Mixing the two is the most common error in NLE oncology items.
- For comparison questions (benign vs. malignant), use a table format with at least four characteristics — it is faster to write, easier to read, and demonstrates organized clinical thinking that examiners reward.
- Cite Philippine context where relevant — mentioning RA 11215 (NICCA), the DOH, HPV vaccine, or leading cancers in the Philippines (breast, lung, cervical) shows applied knowledge and earns extra credit in extended-answer items.
- Never leave the carcinogenesis steps incomplete — always write all three: Initiation, Promotion, and Progression. Stopping at two will cost you a mark even if your explanation of the first two is perfect.
- For screening/prevention questions, classify your answer as primary prevention (remove risk) or secondary prevention (early detection) before listing examples. This framing signals higher-order thinking to examiners.
- In case-study or clinical scenario items, always apply the nursing process framework: assess the warning signs, identify the nursing diagnosis, state the priority intervention, and provide patient teaching. This ADPIE structure maximizes marks on longer questions.
Ready to practise for the NLE 2026?
Super Tutor's AI review plan adapts to your weak areas and builds a weekly practice schedule around your target NLE exam date.